Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

neuroendocrine

  • You have access
    68Ga-DOTATOC Imaging of Neuroendocrine Tumors: A Systematic Review and Metaanalysis
    Michael M. Graham, Xiaomei Gu, Timothy Ginader, Patrick Breheny and John J. Sunderland
    Journal of Nuclear Medicine September 1, 2017, 58 (9) 1452-1458; DOI: https://doi.org/10.2967/jnumed.117.191197
  • You have access
    Norepinephrine Transporter as a Target for Imaging and Therapy
    Neeta Pandit-Taskar and Shakeel Modak
    Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 39S-53S; DOI: https://doi.org/10.2967/jnumed.116.186833
  • You have access
    Clinical History of the Theranostic Radionuclide Approach to Neuroendocrine Tumors and Other Types of Cancer: Historical Review Based on an Interview of Eric P. Krenning by Rachel Levine
    Rachel Levine and Eric P. Krenning
    Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 3S-9S; DOI: https://doi.org/10.2967/jnumed.116.186502
  • You have access
    Localization of Unknown Primary Site with 68Ga-DOTATOC PET/CT in Patients with Metastatic Neuroendocrine Tumor
    Yusuf Menda, Thomas M. O’Dorisio, James R. Howe, Michael Schultz, Joseph S. Dillon, David Dick, G. Leonard Watkins, Timothy Ginader, David L. Bushnell, John J. Sunderland, Gideon K.D. Zamba, Michael Graham and M. Sue O’Dorisio
    Journal of Nuclear Medicine July 1, 2017, 58 (7) 1054-1057; DOI: https://doi.org/10.2967/jnumed.116.180984
  • You have access
    Dissociation Between Brown Adipose Tissue 18F-FDG Uptake and Thermogenesis in Uncoupling Protein 1–Deficient Mice
    Mohammed K. Hankir, Mathias Kranz, Susanne Keipert, Juliane Weiner, Sille G. Andreasen, Matthias Kern, Marianne Patt, Nora Klöting, John T. Heiker, Peter Brust, Swen Hesse, Martin Jastroch and Wiebke K. Fenske
    Journal of Nuclear Medicine July 1, 2017, 58 (7) 1100-1103; DOI: https://doi.org/10.2967/jnumed.116.186460
  • You have access
    The Impact of Somatostatin Receptor–Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis
    Martin Barrio, Johannes Czernin, Stefano Fanti, Valentina Ambrosini, Ina Binse, Lin Du, Matthias Eiber, Ken Herrmann and Wolfgang P. Fendler
    Journal of Nuclear Medicine May 1, 2017, 58 (5) 756-761; DOI: https://doi.org/10.2967/jnumed.116.185587
  • You have access
    Clinical Translation of a Click-Labeled 18F-Octreotate Radioligand for Imaging Neuroendocrine Tumors
    Suraiya R. Dubash, Nicholas Keat, Paola Mapelli, Frazer Twyman, Laurence Carroll, Kasia Kozlowski, Adil Al-Nahhas, Azeem Saleem, Mickael Huiban, Ryan Janisch, Andrea Frilling, Rohini Sharma and Eric O. Aboagye
    Journal of Nuclear Medicine August 1, 2016, 57 (8) 1207-1213; DOI: https://doi.org/10.2967/jnumed.115.169532
  • You have access
    68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
    Stephen A. Deppen, Jeffrey Blume, Adam J. Bobbey, Chirayu Shah, Michael M. Graham, Patricia Lee, Dominique Delbeke and Ronald C. Walker
    Journal of Nuclear Medicine June 1, 2016, 57 (6) 872-878; DOI: https://doi.org/10.2967/jnumed.115.165803
  • You have access
    Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors
    Stephen A. Deppen, Eric Liu, Jeffrey D. Blume, Jeffrey Clanton, Chanjuan Shi, Laurie B. Jones-Jackson, Vipul Lakhani, Richard P. Baum, Jordan Berlin, Gary T. Smith, Michael Graham, Martin P. Sandler, Dominique Delbeke and Ronald C. Walker
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 708-714; DOI: https://doi.org/10.2967/jnumed.115.163865
  • You have access
    The Somatostatin Analog 188Re-P2045 Inhibits the Growth of AR42J Pancreatic Tumor Xenografts
    Carol A. Nelson, Michael T. Azure, Christopher T. Adams and Kurt R. Zinn
    Journal of Nuclear Medicine December 1, 2014, 55 (12) 2020-2025; DOI: https://doi.org/10.2967/jnumed.114.140780

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
SNMMI

© 2025 SNMMI

Powered by HighWire